DNA Methylation in Adipose Tissue and Metabolic Syndrome
Funding
Conflicts of Interest
References
- Carson, C.; Lawson, H.A. Epigenetics of metabolic syndrome. Physiol. Genom. 2018, 50, 947–955. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agosti, M.; Tandoi, F.; Morlacchi, L.; Bossi, A. Nutritional and metabolic programming during the first thousand days of life. Pediatr. Med. Chir. 2017, 39, 157. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Castellano-Castillo, D.; Moreno-Indias, I.; Sanchez-Alcoholado, L.; Ramos-Molina, B.; Alcaide-Torres, J.; Morcillo, S.; Ocana-Wilhelmi, L.; Tinahones, F.; Queipo-Ortuno, M.I.; Cardona, F. Altered adipose tissue DNA methylation status in metabolic syndrome: Relationships between global DNA methylation and specific methylation at adipogenic, lipid metabolism and inflammatory candidate genes and metabolic variables. J. Clin. Med. 2019, 8, 87. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ling, C.; Rönn, T. Epigenetics in human obesity and type 2 diabetes. Cell Metab. 2019, 29, 1028–1044. [Google Scholar] [CrossRef] [Green Version]
- Suzuki, M.M.; Bird, A. DNA methylation landscapes: Provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9, 465–476. [Google Scholar] [CrossRef]
- Fouad, M.A.; Salem, S.E.; Hussein, M.M.; Zekri, A.R.N.; Hafez, H.F.; El Desouky, E.D.; Shouman, S.A. Impact of global DNA methylation in treatment outcome of colorectal cancer patients. Front. Pharmacol. 2018, 9, 1173. [Google Scholar] [CrossRef]
- Dabrowski, M.J.; Wojtas, B. Global DNA methylation patterns in human gliomas and their interplay with other epigenetic modifications. Int. J. Mol. Sci. 2019, 20, 3478. [Google Scholar] [CrossRef] [Green Version]
- Mutize, T.; Mkandla, Z.; Nkambule, B.B. Global and gene-specific DNA methylation in adult type 2 diabetic individuals: A protocol for a systematic review. Syst. Rev. 2018, 7, 46. [Google Scholar] [CrossRef]
- Heerwagen, M.J.R.; Miller, M.R.; Barbour, L.A.; Friedman, J.E. Maternal obesity and fetal metabolic programming: A fertile epigenetic soil. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299, R711–R722. [Google Scholar] [CrossRef] [Green Version]
- Kitsiou-Tzeli, S.; Tzetis, M. Maternal epigenetics and fetal and neonatal growth. Curr. Opin. Endocrinol. Diabetes Obes. 2017, 24, 43–46. [Google Scholar] [CrossRef]
- Tozzi, M.G.; Moscuzza, F.; Michelucci, A.; Lorenzoni, F.; Cosini, C.; Ciantelli, M.; Ghirri, P. ExtraUterine Growth Restriction (EUGR) in preterm infants: Growth patterns, nutrition, and epigenetic markers. A pilot study. Front. Pediatr. 2018, 6, 408. [Google Scholar] [CrossRef] [PubMed]
- Chen, P.Y.; Chu, A.; Liao, W.W.; Rubbi, L.; Janzen, C.; Hsu, F.M.; Thamotharan, S.; Ganguly, A.; Lam, L.; Montoya, D.; et al. Prenatal growth patterns and birthweight are associated with differential DNA methylation and gene expression of cardiometabolic risk genes in human placentas: A discovery-based approach. Reprod. Sci. 2018, 25, 523–539. [Google Scholar] [CrossRef] [PubMed]
- Moore, L.D.; Le, T.; Fan, G. DNA methylation and its basic function. Neuropsychopharmacology 2013, 38, 23–38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Botta, M.; Audano, M.; Sahebkar, A.; Sirtori, C.R.; Mitro, N.; Ruscica, M. PPAR agonists and metabolic syndrome: An established role? Int. J. Mol. Sci. 2018, 19, 1197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, S.; Yang, B.; Du, Y.; Lin, Y.; Liu, J.; Huang, S.; Zhang, A.; Jia, Z.; Zhang, Y. Targeting PPARα for the treatment and understanding of cardiovascular diseases. Cell. Physiol. Biochem. 2018, 51, 2760–2775. [Google Scholar] [CrossRef] [PubMed]
- Brocker, C.N.; Patel, D.P.; Velenosi, T.J.; Kim, D.; Yan, T.; Yue, J.; Li, G.; Krausz, K.W.; Gonzalez, F.J. Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice. J. Lipid Res. 2018, 59, 2140–2152. [Google Scholar] [CrossRef] [Green Version]
- Barak, Y.; Kim, S. Genetic manipulations of PPARs: Effects on obesity and metabolic disease. PPAR Res. 2007, 2007, 12781. [Google Scholar] [CrossRef]
- Staels, B.; Maes, M.; Zambon, A. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5, 542–553. [Google Scholar] [CrossRef]
- Han, L.; Shen, W.J.; Bittner, S.; Kraemer, F.B.; Azhar, S. PPARs: Regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ. Future Cardiol. 2017, 13, 279–296. [Google Scholar] [CrossRef]
- ALJohani, A.M.; Syed, D.N.; Ntambi, J.M. Insights into stearoyl-CoA desaturase-1 regulation of systemic metabolism. Trends Endocrinol. Metab. 2017, 28, 831–842. [Google Scholar] [CrossRef]
- Maury, E.; Brichard, S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol. 2010, 314, 1–16. [Google Scholar] [CrossRef]
- Yaribeygi, H.; Farrokhi, F.R.; Butler, A.E.; Sahebkar, A. Insulin resistance: Review of the underlying molecular mechanisms. J. Cell. Physiol. 2019, 234, 8152–8161. [Google Scholar] [CrossRef]
- Virdis, A.; Colucci, R.; Bernardini, N.; Blandizzi, C.; Taddei, S.; Masi, S. Microvascular endothelial dysfunction in human obesity: Role of TNF-α. J. Clin. Endocrinol. Metab. 2018, 104, 341–348. [Google Scholar] [CrossRef] [Green Version]
- Kern, L.; Mittenbühler, M.J.; Vesting, A.J.; Ostermann, A.L.; Wunderlich, C.M.; Wunderlich, F.T. Obesity-induced TNFα and IL-6 signaling: The missing link between obesity and inflammation-driven liver and colorectal cancers. Cancers 2018, 11, 24. [Google Scholar] [CrossRef] [Green Version]
- Belizário, J.E.; Faintuch, J.; Garay-Malpartida, M. Gut microbiome dysbiosis and immunometabolism: New frontiers for treatment of metabolic diseases. Mediat. Inflamm. 2018, 2018, 2037838. [Google Scholar] [CrossRef]
- Qin, Y.; Wade, P.A. Crosstalk between the microbiome and epigenome: Messages from bugs. J. Biochem. 2017, 163, 105–112. [Google Scholar] [CrossRef] [Green Version]
- Cuevas-Sierra, A.; Ramos-Lopez, O.; Riezu-Boj, J.I.; Milagro, F.I.; Martinez, J.A. Diet, gut microbiota, and obesity: Links with host genetics and epigenetics and potential applications. Adv. Nutr. 2019, 10, S17–S30. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Panchal, S.K.; Brown, L. DNA Methylation in Adipose Tissue and Metabolic Syndrome. J. Clin. Med. 2020, 9, 2699. https://doi.org/10.3390/jcm9092699
Panchal SK, Brown L. DNA Methylation in Adipose Tissue and Metabolic Syndrome. Journal of Clinical Medicine. 2020; 9(9):2699. https://doi.org/10.3390/jcm9092699
Chicago/Turabian StylePanchal, Sunil K., and Lindsay Brown. 2020. "DNA Methylation in Adipose Tissue and Metabolic Syndrome" Journal of Clinical Medicine 9, no. 9: 2699. https://doi.org/10.3390/jcm9092699